M. Erkisi Et Al. , "The use of R-MET HU 6-CSF in combination with high and standard doses of ifosfamide and doxorubicin in the patients with advanced soft tissue sarcoma," EUROPEAN JOURNAL OF CANCER , pp.855, 1995
Erkisi, M. Et Al. 1995. The use of R-MET HU 6-CSF in combination with high and standard doses of ifosfamide and doxorubicin in the patients with advanced soft tissue sarcoma. EUROPEAN JOURNAL OF CANCER , 855.
Erkisi, M., Erkurt, E., Ozbarlas, S., Burgut, R., Doran, F., & Seyrek, E., (1995). The use of R-MET HU 6-CSF in combination with high and standard doses of ifosfamide and doxorubicin in the patients with advanced soft tissue sarcoma. EUROPEAN JOURNAL OF CANCER , 855.
Erkisi, M Et Al. "The use of R-MET HU 6-CSF in combination with high and standard doses of ifosfamide and doxorubicin in the patients with advanced soft tissue sarcoma," EUROPEAN JOURNAL OF CANCER , 855, 1995
Erkisi, M Et Al. "The use of R-MET HU 6-CSF in combination with high and standard doses of ifosfamide and doxorubicin in the patients with advanced soft tissue sarcoma." EUROPEAN JOURNAL OF CANCER , pp.855, 1995
Erkisi, M. Et Al. (1995) . "The use of R-MET HU 6-CSF in combination with high and standard doses of ifosfamide and doxorubicin in the patients with advanced soft tissue sarcoma." EUROPEAN JOURNAL OF CANCER , p.855.
@article{article, author={M Erkisi Et Al. }, title={The use of R-MET HU 6-CSF in combination with high and standard doses of ifosfamide and doxorubicin in the patients with advanced soft tissue sarcoma}, journal={EUROPEAN JOURNAL OF CANCER}, year=1995, pages={855} }